Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-01

Clinical Trial Update: Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a Carmustine, Etoposide, and Cyclophosphamide regimen with stem cell transplant for HIV-associated lymphoma; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Carmustine (carmustine)
  • Etoposide (Etoposide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING